EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC

Abstract

Translation initiation is orchestrated by the cap binding and 43S preinitiation complexes (PIC). Eukaryotic initiation factor 1A (EIF1A) is essential for recruitment of the ternary complex and for assembling the 43S PIC. Recurrent EIF1AX mutations in papillary thyroid cancers are mutually exclusive with other drivers, including RAS . EIF1AX mutations are enriched in advanced thyroid cancers, where they display a striking co-occurrence with RAS , which cooperates to induce tumorigenesis in mice and isogenic cell lines. The C-terminal EIF1AX-A113splice mutation is the most prevalent in advanced thyroid cancer. EIF1AX-A113splice variants stabilize the PIC and induce ATF4, a sensor of cellular stress, which is co-opted to suppress EIF2α phosphorylation, enabling a general increase in protein synthesis. RAS stabilizes c-MYC, an effect augmented by EIF1AX-A113splice. ATF4 and c-MYC induce expression of amino acid transporters and enhance sensitivity of mTOR to amino acid supply. These mutually reinforcing events generate therapeutic vulnerabilities to MEK, BRD4, and mTOR kinase inhibitors. SIGNIFICANCE:Mutations of EIF1AX, a component of the translation PIC, co-occur with RAS in advanced thyroid cancers and promote tumorigenesis. EIF1AX-A113splice drives an ATF4-induced dephosphorylation of EIF2α, resulting in increased protein synthesis. ATF4 also cooperates with c-MYC to sensitize mTOR to amino acid supply, thus generating vulnerability to mTOR kinase inhibitors.EIF1AX is an essential subunit of the translation PIC (10, 12). We performed coimmunoprecipitation (co-IP) experiments to probe for possible aberrant interactions of EIF1AX mutants with components of the TC and the PIC. IP of Research.on July 10, 2020.

Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer

“…A similar approach was performed in PDTC and ATC [55]. Notably, functional studies demonstrated that EIF1AX mutations cooperate with RAS in inducing thyroid tumorigenesis and sensitize tumor cells to mTOR inhibition [57].…”

Update on uveal melanoma: Translational research from biology to clinical practice (Review)

“…Mutations affecting EIF1AX, which participate in the onset of translation, has no influence on metastases and more work is needed to establish possible relations between both (86). Of note, EIF1AX mutations seem to exert a synergistic effect on Ras mutations in certain types of tumours, such as ovary and thyroid (93,94). The low proportions of uveal melanoma cell mutations in these genes may explain why EIF1AX is not associated with a greater metastasis risk in the tumours.…”

Impact of Eukaryotic Translation Initiation Factors on Breast Cancer: Still Much to Investigate

“…EIF1AX mutations are common in advanced thyroid cancers, accompanied by a simultaneous occurrence of RAS mutations. The cooperation of EIF1AX and RAS mutations can induce the formation of tumors in mice [18]. The co-occurrence and subsequent co-expression of mutant NRAS and EIF1AX promoted proliferation and survival in ovarian low grade serous carcinomas [19].…”